🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: * PSA (prostate specific antigen) is a protein found on normal...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-05-11
Trial ID
NCT00972309
This phase II trial tests how well a survivin peptide vaccine called SurVax...
Status
Not Yet Recruiting
Location
Rocky Mountain Regional VA Medical Center
Start Date
2026-10-01
Trial ID
NCT07169617
This study will evaluate the safety of administering a peptide vaccine cons...
Status
Completed
Location
Duke Comprehensive Cancer Center
Start Date
2007-03
Trial ID
NCT00437502
Treatments Being Tested
This study will evaluate the safety and feasibility of administering a pept...
Status
Completed
Location
Duke Comprehensive Cancer Center
Start Date
2007-06
Trial ID
NCT00674791
Treatments Being Tested
Goal: To characterize the cellular events that occur in vivo after vaccinat...
Status
Completed
Location
University of Virginia
Start Date
2004-06
Trial ID
NCT00912574
Treatments Being Tested
RATIONALE: Vaccines made from a peptide may help the body build an effectiv...
Status
Unknown
Location
Mayo Clinic Scottsdale
Start Date
2005-05
Trial ID
NCT00454168
Treatments Being Tested
The purpose of this study is to determine whether the experimental vaccine ...
Status
Completed
Location
The University of Chicago
Start Date
2003-04
Trial ID
NCT00203892
Treatments Being Tested
This phase IIa trial compares the safety and effect of temozolomide combine...
Status
Suspended
Location
Roswell Park Cancer Institute
Start Date
2026-10-15
Trial ID
NCT06202066
RATIONALE: Vaccines made from peptides that are found on melanoma cells may...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1998-05
Trial ID
NCT00003362
Treatments Being Tested
RATIONALE: Vaccines made from peptides may make the body build an immune re...
Status
Terminated
Location
University of Virginia Cancer Center
Start Date
2003-03-24
Trial ID
NCT00091286
Treatments Being Tested